How social responsibility M&A performed in the pharmaceutical industry in Q2 2023

In value terms, social responsibility-related deal activity remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal volume increased by 50% in Q2 2023 versus the previous quarter.

For further understanding of GlobalData’s ESG in Sectors – Report Bundle (8 Reports), buy the report here.

This content was updated on 18 July 2023

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.

Breakthrough in artificial sugars could revolutionize disease diagnosis and treatment

Scientists have found a way to create artificial sugars that could lead to better ways to diagnose and treat diseases more accurately than ever before.

September 16, 2024

MarketingRx roundup: Cannes ad festival speakers to include Pfizer, Novo Nordisk; AZ adds TV commercial to NHL collab

Pharma companies set for Cannes ad creativity festival: Pfizer and Novo Nordisk are both set to take the main stages at Cannes’ advertising confab this

April 24, 2024

First wearable camera system detects medication errors with AI

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence, detects potential errors in medication

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.